175591-09-0 (3-[(1R,2R)-3-(二甲基氨基)-1-乙基-2-甲基丙基]苯酚盐酸盐,Phenol,3-[(1R,2R)-3-(dimethylamino)-1-ethyl-2-methylpropyl]-, hydrochloride (1:1))

3-[(1R,2R)-3-(二甲基氨基)-1-乙基-2-甲基丙基]苯酚盐酸盐;3-((1R,2R)-3-(二甲基氨基)-1-乙基-2-甲基丙基)苯酚;Tapentadol hcl 盐酸他喷他多;肌基质蛋白;他喷他多盐酸盐;盐酸他喷他多;盐酸他喷他多标准品;(-)-(1R,2R)-3-(3-二甲氨基-1-乙基-2-甲基丙基)苯酚盐酸盐;3-[(1R,2R)-3-(二甲基氨基)-1-乙基-2-甲基丙基]苯酚盐酸盐(盐酸他喷他多);

Phenol,3-[(1R,2R)-3-(dimethylamino)-1-ethyl-2-methylpropyl]-, hydrochloride (1:1);3-((2R,3R)-1-(Dimethylamino)-2-methylpentan-3-yl)phenol hydrochloride;Tapentadol;Tapentadol HCl;Tapentadol Hydrochlo;Tapentadol Hydrochloride;Tapentadol hydrochloride solution;3-[(1R,2R)-3-(Dimethylamino)-1-ethyl-2-methylpropyl]phenol Hydrochloride;Phenol,3-[(1R,2R)-3-(diMethylaMino)-1-ethyl-2-Methylpropyl]-,(HCl salt);Tapentadol (hydrochloride);Tapentadol (hydrochloride) (CRM);benzyl hydrogen (3-(((2R,3S)-2-((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholino)methyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)phosphonate;3-[(1R,2R)-3-(DiMethylaMino)-1-ethyl-2-Methylpro;Phenol, 3-[(1R,2R)-3-(diMethylaMino)-1-ethyl-2-Methylpropyl]-, (HCl salt);AMY25232;TAPENTADOL HYDROCHLORIDE (EP MONOGRAPH);(-)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol hydrochloride;PHENOL, 3-((1R,2R)-3-(DIMETHYLAMINO)-1-ETHYL-2-METHYLPROPYL)-, HYDROCHLORIDE;DTXSID00938677;PHENOL, 3-(3-(DIMETHYLAMINO)-1-ETHYL-2-METHYLPROPYL)-, HYDROCHLORIDE, (R-(R*,R*))-;3-((1R,2R)-3-(Dimethylamino)-1-ethyl-2-methylpropyl)phenol hydrochloride;D10199;3-[(1r,2r)-3-(dimethylamino)-1-ethyl-2-methylpropyl]phenol monohydrochloride;Tapentadol.HCl;JNS024;JNS-024 ER;TAPENTADOL HYDROCHLORIDE [EP MONOGRAPH];UNII-71204KII53;PHENOL, 3-((1R,2R)-3-(DIMETHYLAMINO)-1-ETHYL-2-METHYLPROPYL)-, HYDROCHLORIDE (1:1);(-)-(1r,2r)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol hydrochloride;TAPENTADOL HYDROCHLORIDE (MART.);3-((1R,2R)-3-(Dimethylamino)-1-ethyl-2-methylpropyl)phenol monohydrochloride;SCHEMBL238138;3-[(2R,3R)-1-(dimethylamino)-2-methylpentan-3-yl]phenol;hydrochloride;TAPENTADOL HYDROCHLORIDE [JAN];CG5503 HYDROCHLORIDE;AKOS016842888;BN-200 HYDROCHLORIDE;Phenol, 3-[(1R,2R)-3-(dimethylamino)-1-ethyl-2-methylpropyl]-, hydrochloride (1:1);Tapentadol.HCl, 1mg/ml in Methanol;TAPENTADOL HYDROCHLORIDE [VANDF];R-331333;CG5503 ER;3-[1-(Dimethylamino)-2-methylpentan-3-yl]phenol--hydrogen chloride (1/1);Tapentadol Hydrochloride (1.0 mg/mL in Methanol);3-((1R,2R)-3-(dimethylamino)-1-ethyl-2-methylpropyl)-phenol hydrochloride;AC-32018;3-((1R,2R)-3-(dimethylamino)-1-ethyl-2-methylpropyl) phenol hydrochloride;ZELFLGGRLLOERW-YECZQDJWSA-N;Palexia SR;TAPENTADOL HYDROCHLORIDE [ORANGE BOOK];71204KII53;NucyntaER;Q27265914;175591-09-0 (HCl);TAPENTADOL HYDROCHLORIDE [MI];TAPENTADOL HYDROCHLORIDE [MART.];R331333;CG-5503 HYDROCHLORIDE;Tapentadol hydrochloride (JAN);Palexia;Nucynta (TN);TAPENTADOL HYDROCHLORIDE [WHO-DD];Nucynta;Tapentadol Hydrochloride ER;CHEMBL1201777;Palexia retard;Nucynta ER;HY-70042A;175591-09-0;CS-0879;Tapentadol.HCl, 1mg/ml in Methanol (as free base);Hydroxy Tapentadol Hydrochloride;BT182778;

MFCD00944992

ZELFLGGRLLOERW-YECZQDJWSA-N

1S/C14H23NO.ClH/c1-5-14(11(2)10-15(3)4)12-7-6-8-13(16)9-12;/h6-9,11,14,16H,5,10H2,1-4H3;1H/t11-,14+;/m0./s1

Cl.OC1=CC=CC(=C1)[C@H](CC)[C@@H](C)CN(C)C